You Position: Home > Paper

The clinical observation of bevacizumab intravitreal injection as adjunctive treatment for laser coagulation to treat retinopathy of prematurity

( views:773, downloads:245 )
Author:
No author available
Journal Title:
Chinese Journal of Ocular Fundus Diseases
Issue:
1
DOI:
No doi available
Key Word:
视网膜病,早产儿/药物疗法;激光凝固术;抗体,单克隆/治疗应用;血管内皮生长因子类;Retinopathy of prematurity/drug therapy;Laser coagulation;Antibodies,monoclonal/therapeutic use;Vascular endothelial growth factors

Abstract: Objective To observe the application and effectiveness of bevacizumab intravitreal injection as adjunctive treatment for laser coagulation to treat retinopathy of prematurity (ROP).Methods From March 2008 to October 2010,17 infants (31 eyes) with ROP received bevacizumab intravitreal injection and were analyzed.Ten infants were male (18 eyes) and 7 were female (13 eyes).Their gestational age was from 24.7 to 31.0 weeks,with a mean of (28.2±1.9) weeks.Their birth weight was from 750 to 1600 grams,with a mean of (1150 ± 264) grams.The indications for treatment included poor papillary dilation and refractive media opacity precluding complete laser coagulation and that ROP could not be controlled after complete laser coagulation treatment.The duration of follow-up was 1.4 to 40.8 months,with a mean of (20.8±13.2) months.It was noted whether the diseases were completely controlled or not,unfavourable structural outcome occurred or not and if there were complications regarding treatment.Results During the follow-up of all 31 eyes,ROP of 27 eyes (87.0%) was controlled by bevacizumab intravitreal injection as adjunctive treatment for laser coagulation. Increasing neovascularization and traction retinal detachment occurred in 2 eyes (6.5 %).These 2 eyes underwent vitreoretinal surgery.The posterior retinal structure returned to normal in 1 eye and posterior vitreoretinal traction occurred in 1 eye.After bevacizumab intravitreal injection ROP continued progressing and traction retina detachment occurred in 2 eyes.The overall health of this infant remained good during and after operation.No systemic adverse drug reactions were found.No endophthalmitis occurred. No ocular complications such as corneal burn,cataract,and anterior segmental ischemia were found.Conclusions During the follow-up,the effectiveness of bevacizumab intravitreal injection as adjunctive treatment for laser coagulation to treat ROP was positive. No complications regarding the treatment were found.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn